PASQUALI, RENATO
 Distribuzione geografica
Continente #
NA - Nord America 10.611
EU - Europa 7.068
AS - Asia 3.458
AF - Africa 369
SA - Sud America 39
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.566
Nazione #
US - Stati Uniti d'America 10.568
GB - Regno Unito 2.316
CN - Cina 1.311
IT - Italia 930
SG - Singapore 882
SE - Svezia 876
DE - Germania 875
VN - Vietnam 770
RU - Federazione Russa 463
UA - Ucraina 463
IN - India 361
FR - Francia 279
IE - Irlanda 279
ZA - Sudafrica 170
EE - Estonia 162
CH - Svizzera 114
TG - Togo 108
FI - Finlandia 83
BG - Bulgaria 64
CI - Costa d'Avorio 37
BE - Belgio 36
CA - Canada 33
NL - Olanda 33
JO - Giordania 30
SC - Seychelles 27
AT - Austria 22
GR - Grecia 22
IR - Iran 22
NG - Nigeria 22
BR - Brasile 20
JP - Giappone 20
HK - Hong Kong 13
AU - Australia 11
RO - Romania 9
CL - Cile 8
LB - Libano 8
ES - Italia 7
EU - Europa 6
HN - Honduras 6
ID - Indonesia 6
PL - Polonia 6
TR - Turchia 6
AR - Argentina 5
UZ - Uzbekistan 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
HR - Croazia 4
KZ - Kazakistan 4
MD - Moldavia 4
PE - Perù 4
AL - Albania 3
EG - Egitto 3
NO - Norvegia 3
PK - Pakistan 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BZ - Belize 2
IQ - Iraq 2
KR - Corea 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 21.566
Città #
Southend 2.131
Fairfield 1.492
Ashburn 1.211
Singapore 738
Woodbridge 711
Wilmington 676
Seattle 663
Chandler 660
Houston 599
Cambridge 472
Princeton 415
Dong Ket 410
Santa Clara 409
Ann Arbor 373
Jacksonville 305
Dublin 278
Boardman 227
Bologna 220
Nanjing 196
Westminster 194
Padova 181
Berlin 121
Lomé 108
Saint Petersburg 100
Shenyang 100
Jinan 96
Bern 92
San Diego 91
Beijing 83
Helsinki 73
Sofia 64
Nanchang 63
Mülheim 61
Hebei 57
Changsha 56
Guangzhou 54
Tianjin 51
Bremen 46
Milan 45
New York 39
Redwood City 39
Abidjan 37
Falls Church 36
Turin 36
Brussels 35
Dearborn 34
Jiaxing 34
Norwalk 34
Olalla 34
Medford 31
Redmond 31
Amman 30
Yubileyny 30
Los Angeles 29
Shanghai 29
Des Moines 27
Mahé 25
Hangzhou 24
Zhengzhou 24
Haikou 23
Abeokuta 22
Taizhou 21
Florence 20
Ningbo 20
Verona 20
San Venanzo 19
Taiyuan 19
Lanzhou 17
Xi'an 17
Tokyo 16
Chicago 15
Falkenstein 15
Kuban 15
Naples 15
Toronto 15
Phoenix 14
Rome 14
Vienna 13
Moscow 12
Wuhan 12
Bühl 11
Frankfurt am Main 11
London 11
Buffalo 10
Dronten 10
Hong Kong 10
Kunming 10
Lappeenranta 10
San Jose 10
Vicenza 10
Costa Mesa 9
Foshan 9
Fuzhou 9
Nuremberg 9
Shenzhen 9
Cagliari 8
Chengdu 8
Clearwater 8
Frankfurt Am Main 8
Kiev 8
Totale 15.102
Nome #
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society 547
Predictors of weight loss and maintenance in patients treated with antiobesity drugs. 477
Defining hyperandrogenism in women with polycystic ovary syndrome: A challenging perspective 204
Centenarians’ offspring as a model of healthy aging: a reappraisal of the data on Italian subjects and a comprehensive overview 193
Behavioral, socio-environmental, educational and demographic correlates of excess body weight in Italian adolescents and young adults 186
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. 184
Active and total ghrelin concentrations in the newborn 182
Acyl ghrelin and metabolic hormones in pregnant and lactating sows. 181
Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT predictive score 181
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. 181
Androgen Profiling by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women 172
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. 169
Aldosterone and type 2 diabetes mellitus 168
11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion 167
Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study 166
A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. 165
A new interaction to come: Ghrelin and steroid hormones 163
Heterogeneity of thyroid function and impact of peripheral thyroxine deiodination in centenarians and semi-supercentenarians: association with functional status and mortality. 159
Combined Aldosterone and Cortisol Secretion by Adrenal Incidentaloma 156
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. 156
Acute severe male hypo-testosteronemia affects central motor command in humans 154
Circulating endocannabinoids are differentially modulated during the oral glucose tolerance test 151
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women 151
New insights on diabetes in Turner syndrome: results from an observational study in adulthood 146
Anti-müllerian hormone and insulin-like 3 levels in healthy normal-weight ovulatory and anovulatory eumenorrheic late adolescent females: potential early biomarkers of ovarian dysfunction? 145
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 144
Cortisol, energy intake, and food frequency in overweight/obese women 143
Cannabinoid type 1 receptor: another arrow in the adipocytes' bow 143
The Significance of Low Testosterone Levels in Obese Men 140
Abdominal adiposity by ultrasonography: a "pocket" database for reference standard in Italian people 140
Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes 137
The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. 136
A placebo controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effects on anthropometric, metabolic and biochemical parameters 136
Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes 135
Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome 134
Insulin sensitizers in polycystic ovary syndrome 133
Il sistema endocannabinoide e il controllo del metabolismo energetico: fisiologia e fisiopatologia 133
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism 132
Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic states 132
The endocannabinoid system and the treatment of obesity. 131
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases. 129
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome. 128
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. 127
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. 127
Circulating obestatin levels and the grelin/obestatin ratio in obese women 125
The empowerment of translational research: lessons from laminopathies. 125
Clinical assessment of allostatic overload in adolescent and young women with hyperandrogenic states 124
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 124
Obesity-related proliferative diseases: The interaction between adipose tissue and estrogens in post-menopausal women 124
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. 123
Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women. 121
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 121
Psychological aspects of hyperandrogenic states in late adolescent and young women. 121
Cannabinoid receptor antagonists and the metabolic syndrome: Novel promising therapeutical approaches. 121
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. 120
Le aree cerebrali ed i neurotrasmettitori deputati al senso di sazietà, piacere e dipendenza: quale ruolo nel mantenimento dell'obesità? 119
In vivo dissolution of levothyroxine soft gel capsules 119
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk 119
Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone 119
Energy balance regulation by endocannabinoids at central and peripheral levels 118
Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. 116
Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. 116
Ghrelin and reproductive disorders. 116
EFFECT OF FASTING AND REFEEDING ON PLASMA GHRELIN LEVELS IN PREPUBERTAL GILTS 116
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors 116
Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. 115
A comprehensive approach in diagnosing the polycystic ovary syndrome 115
Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. 113
Metabolic effects of obesity on reproduction. 113
Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin 113
Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. 113
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 113
Salivary cortisol and cortisone responses to short-term psychological stress challenge in late adolescent and young women with different hyperandrogenic states 113
La surrenectomia laparoscopica: le dimensioni della lesione costituiscono un limite all'approccio mini-invasivo? 112
Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography-tandem mass spectrometry 112
Peripheral endocannabinoid system-mediated actions of rimonabant on growth hormone secretion are ghrelin-dependent. 111
Obesity, fat distribution and infertility. 110
Role of sex hormones in modulation of brown adipose tissue activity 110
Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS 110
Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. 110
Revisiting hyper- and hypo-androgenism by tandem mass spectrometry. 109
Stress-related development of obesity and cortisol in women 109
Relationships between total and regional adiposity and epicardial fat in obese women: how can dual-energy X-ray absorptiometry be associated with echocardiographic epicardial fat measurements? 108
Prescription medications for the treatment of obesity 108
No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours 108
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome 108
Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome. 107
Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution 107
Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome. 106
Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern. 106
The endocannabinoid system and energy metabolism 106
Radiological formula for differentiating between secreting and non secreting adrenal adenomas. 106
Clinical manifestations of PCOS 105
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. 105
Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. 105
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. 104
Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity. 104
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study. 104
An exciting challenge for obesity research in Italy: the role of the Journal of Endocrinological Investigation. 104
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. 103
Totale 13.792
Categoria #
all - tutte 57.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.752 0 0 0 0 0 0 0 0 776 384 191 401
2020/20213.071 613 252 81 159 54 199 53 190 259 191 140 880
2021/20223.732 386 148 250 307 320 204 94 249 123 249 831 571
2022/20233.381 421 477 168 478 182 209 102 170 542 217 248 167
2023/20241.362 101 167 64 44 63 164 256 359 20 57 43 24
2024/20252.578 134 695 336 226 675 200 205 72 35 0 0 0
Totale 21.959